The in-licensing team headed by Dr. Harvinder Popli has entered into 44 agreements in the last 5 years of operation. In-licensing as a function started in Ranbaxy in 2005. The agreements have been signed with innovation/technology driven companies from US, Europe and Asia. The deals were done primarily for the Indian market along with markets like Singapore, Malaysia, Vietnam, Cambodia, Myanmar, Philippines, Sri Lanka & in the Middle East region. The deals were signed in therapy areas of Clinical Dermatology, Asthetic Dermatology, CNS, Urology, Oncology, Pain Management, Neutraceuticals, Dental products, Respiratory etc. The in-licensing team is also responsible for pre-launch and project management activities for launching the licensed products within stipulated timelines. As a recognition to her unmatched passion and hard work, recently Dr. Harvinder Popli has been nominated as one of the top 20 business development professionals in the reputed European Business Development newsletter, EuroPlx Business Developer Nov/Dec'2009 edition; weblink.
The winners will be announced at an awards ceremony on Tuesday, January 26 at the Drug Delivery Partnerships International Conference.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment